Study of the Sars-Cov2 Neuroinvasiveness - COVID19
NCT04427254
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
2
Enrollment
NETWORK
Sponsor class
Stopped
enrollment number not reached
Conditions
COVID19
Interventions
DRUG:
Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild